Boardroom Media (CEO News)
At CEO (Boardroom Media) we track over 1,000,000 startups and over 5,000,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top China based CEO’ operating in the Life Science space. If you think a CEO’ is missing from this list, feel free to contact our editor on [email protected].
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Ruiqiang Li
Founder & CEO of Novogene
Dr. Ruiqiang Li, is widely recognized as one of the world’s leading experts in genomics and bioinformatics, owning 17 patents and has authored over 100 publications that have been cited more than 42,000 times. Best known for developing the software SOAP (Short Oligonucleotide Analysis Package) for ultra-fast sequence mapping, variation detection, and de novo genome assembly, Dr. Li has focused the company on being a full-service provider, performing NGS services and providing bioinformatic analysis to fully empower and enable our customers to move forward rapidly and effectively in their scientific endeavors.
Follow Ruiqiang Li:
About Novogene: Novogene is a provider of genomic services and solutions with cutting edge NGS.
John V. Oyler
CEO & Founder of BeiGene
John V. Oyler is our Chairman and Co-Founder, and has served as our Chief Executive Officer and a member of our Board of Directors since 2010. From 2005 to 2009, Mr. Oyler served as President and Chief Executive Officer of BioDuro, LLC, a drug discovery outsourcing company, which was acquired by Pharmaceutical Product Development Inc. in 2010. From 2002 to 2004, Mr. Oyler served as Chief Executive Officer of Galenea Corp., a biopharmaceutical company dedicated to the discovery of novel therapies for central nervous system diseases, which initially were developed at Massachusetts Institute of Technology. From 1997 to 2002, Mr. Oyler was a Founder and the President of Telephia, Inc. which was sold to The Nielsen Company in 2007. From 1997 to 1998, Mr. Oyler served as Co-Chief Executive Officer of Genta Incorporated (NASDAQ: GNTA), an oncology‑focused biopharmaceutical company. Mr. Oyler began his career as a management consultant at McKinsey & Company. Mr. Oyler received his B.S. from Massachusetts Institute of Technology and MBA from Stanford University.
Follow John V. Oyler:
About BeiGene: BeiGene is a life sciences, biotechnology company.
Youzhi Tong
Chief Executive Officer of Suzhou Kintor Pharmaceuticals
– Jointly founded Angion in US with rich entrepreneurial experience in technology companies. – More than 20 years of experience in R&D and management in biopharmaceutical area. – Led major national, provincial and municipal scientific research projects af
Follow Youzhi Tong:
About Suzhou Kintor Pharmaceuticals: Kintor is a pharmaceutical research company.
Ye Yin
CEO of BGI Group
Ye Yin is CEO of BGI Genomics Co., Ltd. He joined BGI in 2002 and played an indispensable role in fighting against SARS, which has become his first achievement in the early career. He has been in charge of all the scientific collaboration business worldwide, from sales activities to market management, and to technical support in BGI. With BGI’s rapid development into the world-leading organization in genomic field and into diagnostics and agriculture industry, he contributed in the acquisition of Complete Genomics in 2013 and the smooth merge of CG with BGI. Ye has abundant experiences on massive lab production and quality management. He has successfully guided several international projects, like “1000 Plant and Animal Reference Genomes project”, “One Million Human Genomes re-sequencing project” and so on. He has several publications of genome research projects and genetic insights into medical research.
Follow Ye Yin:
About BGI Group: BGI Group is one of the world’s largest DNA sequencing service providers.
Frank Wu
Founder & CEO of TransThera Biosciences
Follow Frank Wu:
About TransThera Biosciences: TransThera Biosciences is a biotech company that specializes in the treatment of oncology, cardiovascular, and inflammatory diseases.
Daixing Zhou
CEO of Berry Genomics
Dr. Daixing Zhou is the Chief Executive Officer of Berry Genomics Co., Ltd, located in Beijing, China. Prior to founding Berry Genomics, Dr. Zhou held multiple positions in the next generation sequencing industry, including the Leader of Market Development at Life Technologies Corp., the Head of Sequencing Sales at Illumina-Asia Pacific Japan, and the Director of Bioinformatics at Solexa Inc/Lynx Therapeutics. Dr. Zhou earned his Ph.D. from University of Maryland at Baltimore, and completed his postdoctoral training at Duke University.
Follow Daixing Zhou:
About Berry Genomics: Berry Genomics is a company specializing in developing and commercializing technologies for life sciences and clinical applications.
James Foster
Chief Executive Officer and Founder of Virax Biolabs
James Foster is the Chief Executive Officer and Founder of Virax Biolabs.
Follow James Foster:
About Virax Biolabs: Virax Biolabs is an innovative Biotechnology company focused on the prevention, detection and diagnosis of viral diseases
Jin Zhang
CEO and Founder of DXY
Jin Zhang is the Chief Executive Office and product director of DXY, a media platform focused on the areas of pharmaceuticals and life sciences. He joined DXY in 2008. Zhang began medical practice on the internet in 1999 and has a thorough understanding of web-based design in medical and health fields. He also worked at the first affiliated hospital of the College of Medicine of Zhejiang University. Zhang obtained his degree in medicine from Hsiang-Ya Medical College of Central South University in 2004.
Follow Jin Zhang:
About DXY: DXY is an online healthcare community for doctors, consumers, and healthcare organizations.
Jackie Luan
CEO of Lavector
Jackie Luan started Lavector Technologies after returning from the US where she taught Marketing as an Assistant Professor at Dartmouth’s Tuck School of Business. Using her extensive knowledge gained at Yale (Ph.D.) and teaching MBA courses, she started one of China’s first AI-powered marketing platforms to help large domestic and international companies acquire and retain customers in China. The technology enables real-time image recognition that allows clients discover consumer insights and drive loyalty. Its automatic content syndication service assists companies to acquire customers through location-based precision advertising. Her firm is taking Big Data to the next level.
Follow Jackie Luan:
About Lavector: Lavector Technologies is a venture-backed AI startup that employs real-time image recognition.
Yang Ling
President and Chief Executive Officer of Beijing Gene+ Technology
Doctor of Medicine, Associate Researcher, Master’s Tutor of Chinese Academy of Sciences, Member of Professional Committee of Health Risk Assessment and Control of Chinese Preventive Medicine Institute, engaged in R & D and clinical examination of gene health field for more than ten years, served as Head of Health Department of Huada, Shenzhen Huada Director of clinical examination center, general manager of Tianjin Huada, director of Shenzhen Municipal Key Laboratory of pathogen nucleic acid detection, director of Shenzhen Key Laboratory of Clinical Molecular Diagnosis, director of Tianjin Medical Genomics Engineering Center and director of Tianjin Key Laboratory of Enterprise , Has a wealth of clinical testing and company operating experience.
Follow Yang Ling:
About Beijing Gene+ Technology: Beijing Gene+, also known as Beijing Gene Plus, provides gene testing services for cancer prevention
Zhimin Li
CEO of Annoroad
Follow Zhimin Li:
About Annoroad: Annoroad is leading developer and marketer on genomic innovation technologies for research and clinical market.
Zhimin Li
CEO of Annoroad
Follow Zhimin Li:
About Annoroad: Annoroad is leading developer and marketer on genomic innovation technologies for research and clinical market.
